[Thrombectomy in primary angioplasty]

Gennaro Sardella1, Massimo Mancone, Angelo Di Roma

  • 1Dipartimento di Scienze Cardiovascolari, Respiratorie e Morfologiche, Sapienza Università di Roma, Policlinico Umberto I, Roma. rino.sardella@uniroma1.it

Giornale Italiano Di Cardiologia (2006)
|October 24, 2008
PubMed

Insights

Thrombectomy during primary percutaneous coronary intervention (PCI) helps prevent distal embolization in ST-elevation myocardial infarction patients with visible thrombus. This adjunct therapy improves outcomes despite restored epicardial flow.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Context:

  • Primary percutaneous coronary intervention (PCI) is the standard for ST-elevation myocardial infarction (STEMI).
  • Despite successful epicardial flow restoration, microvascular damage often limits PCI efficacy.
  • Intracoronary thrombus is a frequent complication in STEMI patients undergoing primary PCI.

Purpose:

  • To evaluate the efficacy of thrombectomy as an adjunct to primary PCI in STEMI patients.
  • To assess the role of thrombectomy in preventing distal embolization.
  • To determine if thrombectomy improves outcomes in the presence of visible intracoronary thrombus.

Summary:

  • Primary PCI achieves TIMI 3 flow in over 90% of STEMI patients.
  • Microvascular dysfunction frequently impedes the benefits of primary PCI.
  • Thrombectomy during primary PCI, particularly with visible thrombus, may prevent distal embolization and improve outcomes.

Impact:

  • Thrombectomy represents a potentially valuable adjunct to standard pharmacotherapy in specific STEMI cases.
  • This approach may mitigate microvascular damage and enhance the overall success of primary PCI.
  • Further research can elucidate the long-term benefits of adjunctive thrombectomy in STEMI management.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...